Yorsua, Mivel .
HRN: 25-74-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2024
METRONIDAZOLE 500MG (TAB)
08/24/2024
08/30/2024
PO
500 Mg
Q8
Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes